US authorizes Moderna s COVID-19 vaccine for emergency use
The FDA has cleared a second vaccine to boost efforts at ending the pandemic in the US. Moderna s vaccine will likely be used in harder-to-reach areas of the country due to the relative ease of storing its doses.
The US is the first nation to approve Moderna s COVID-19 vaccine
Moderna s COVID-19 vaccine has become the second to receive the US Food and Drug Administration s authorization for emergency use, as the world s hardest-hit nation grapples with more than 3,000 coronavirus deaths a day. With the availability of two vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing vast numbers of hospitalizations and deaths in the United States each day, said FDA chief Stephen Hahn on Friday.
Virginia to receive nearly 110,000 fewer COVID-19 vaccine doses than promised The reason is unclear
martinsvillebulletin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from martinsvillebulletin.com Daily Mail and Mail on Sunday newspapers.
The Food and Drug Administration on Friday authorized the emergency use of a COVID-19 vaccine developed by Moderna and the National Institutes of Health, essentially doubling the nation’s arsenal for immunizing its healthcare workers and members of other high-risk groups.
The two-dose Moderna vaccine fared well in Phase 3 clinical trials involving more than 30,000 adults, proving to be 94.5% effective at preventing COVID-19 in the roughly seven weeks after the second shot was administered.
The vaccine was created using the same type of technology as the one made by Pfizer and BioNTech, which was authorized late last week and has been administered to hundreds of thousands of Americans since Monday. But Moderna’s vaccine will be shipped to many more locations than Pfizer’s, in large part because it doesn’t require the same ultra-cold storage system.
Q&A on COVID-19 Vaccines
This article is available in both English and Español
English
Español
Two COVID-19 vaccines are now authorized in the U.S. and more are likely to follow. In this story, we answer some common questions about the shots.
For more information about specific vaccines, we’ve created or will be creating individual pages for COVID-19 vaccines that are authorized or likely to be authorized.
The first vaccine that received the Food and Drug Administration’s green light was Pfizer/BioNTech’s two-dose mRNA vaccine, which was authorized via an emergency use authorization, or EUA, on Dec. 11. (For more, please see “A Guide to Pfizer/BioNTech’s COVID-19 Vaccine.”)
Full article FDA announced the authorization the day after the agency s panel of outside experts endorsed its use and a week after the FDA authorized the Pfizer vaccine
Moderna Inc s coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 307,000 lives lost.
The FDA announced the authorization the day after the agency s panel of outside experts endorsed its use and a week after the FDA authorized a vaccine from Pfizer Inc and German partner BioNTech SE.
vimarsana © 2020. All Rights Reserved.